Literature DB >> 7861810

Sweet's syndrome: systemic signs and symptoms and associated disorders.

D L Fett1, L E Gibson, W P Su.   

Abstract

OBJECTIVE: To characterize the findings associated with acute febrile neutrophilic dermatosis (Sweet's syndrome [SS]) and the response of SS to treatment.
DESIGN: We retrospectively reviewed 48 cases of SS encountered at the Mayo Clinic between 1980 and 1992.
MATERIAL AND METHODS: Histopathologic specimens and medical records were studied to determine initial manifestations, patterns of involvement, systemic signs and symptoms (including mucosal, musculoskeletal, hematologic, pulmonary, hepatic, and renal findings), and conditions associated with SS.
RESULTS: In patients with SS, the typical manifestations are the acute onset of tender, erythematous or violaceous nodules or plaques in association with fever, leukocytosis, and dermal neutrophilia. In our study group, the cutaneous lesions most frequently involved the arms and legs. Of our 48 patients, 26 (54%) had a hematopoietic, plasma cell, or malignant disorder, and many of these patients had associated anemia, especially the male patients. No single laboratory finding specifically indicated an association with serious systemic disease. Most patients were treated with a tapering dose of prednisone, which yielded a good response.
CONCLUSION: Clinical acumen and appropriate laboratory tests are the main requirements for detection of hematologic disorders, internal malignant diseases, or other systemic conditions associated with SS.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7861810     DOI: 10.4065/70.3.234

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  23 in total

1.  Retropharyngeal and splenic aseptic abscesses treated with prednisone and cyclophosphamide in a patient with ulcerative colitis.

Authors:  Marc André; Jean-Charles Piette; Camille Frances; Bertrand Wechsler; Isabelle Delevaux; Olivier Aumaître
Journal:  Dig Dis Sci       Date:  2003-06       Impact factor: 3.199

2.  Sweet's syndrome after adalimumab therapy for refractory relapsing polychondritis.

Authors:  Sarah Keidel; Aubretia McColl; Sally Edmonds
Journal:  BMJ Case Rep       Date:  2011-12-21

3.  Successful treatment of ulcerative colitis complicated by Sweet's syndrome by corticosteroid therapy and leukocytapheresis.

Authors:  Tomohiro Terai; Mitsushige Sugimoto; Satoshi Osawa; Ken Sugimoto; Takahisa Furuta; Shigeru Kanaoka; Mutsuhiro Ikuma
Journal:  Clin J Gastroenterol       Date:  2011-03-29

4.  Sweet syndrome secondary to inflammatory bowel disease.

Authors:  Malcolm M Wells; William Stecho; Bret Wehrli; Nitin Khanna
Journal:  Can J Gastroenterol       Date:  2013-03       Impact factor: 3.522

5.  Sweet's Syndrome Presenting in Concordance with Acute Coronary Syndrome.

Authors:  Michael Kassardjian; Vanessa Holland; Tracy Leong; David Horowitz; Jane Hirokane
Journal:  J Clin Aesthet Dermatol       Date:  2012-09

Review 6.  [Skin disorders in malignant hematologic diseases].

Authors:  M Schmid-Wendtner; T Hornung; M Meurer; C-M Wendtner
Journal:  Hautarzt       Date:  2015-08       Impact factor: 0.751

7.  Recurrent necroinflammatory disease of multiple organs and colon. Systemic presentation of inflammatory bowel disease or gut involvement during systemic disorder.

Authors:  G C Actis; A Ottobrelli; B Lavezzo; V Modena; D Regge; A Veltri; C Tomasini; P Puiatti; D Novero; G Verme
Journal:  Dig Dis Sci       Date:  1996-10       Impact factor: 3.199

8.  Sweet's syndrome associated with Hashimoto's thyroiditis.

Authors:  Christina Raissa I Francisco; Perpetua C Patal; Eileen A Cubillan; Iris Thiele Isip-Tan
Journal:  BMJ Case Rep       Date:  2011-08-24

9.  Sweet's syndrome associated with recurrent fever in a patient with trisomy 8 myelodysplastic syndrome.

Authors:  Hideki Hattori; Shiro Hoshida; Shotaro Yoneda
Journal:  Int J Hematol       Date:  2003-05       Impact factor: 2.490

10.  Azathioprine-induced bullous Sweet's syndrome: a rare association.

Authors:  Sugata Narayan Biswas; Partha Pratim Chakraborty; Kripasindhu Gantait; Chittaranjan Bar
Journal:  BMJ Case Rep       Date:  2016-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.